TABLE 1.

Susceptibilities of Acinetobacter spp. and E. coli strains with aac(6′)-Iad to various aminoglycosides

Strain	Hospital	Specimen	MIC (μg/ml) of the following aminoglycosidea:
			KAN	TOB	AMK	ABK	GEN	SISO	ISP	NEO	STR
Acinetobacter genomic species 3, strain A-51	A	Sputum	>1,024	>1,024	1,024	1,024	>1,024	>1,024	>1,024	64	>1,024
A. baumannii A-67	B	Urine	>1,024	64	128	32	8	1,024	256	8	256
A. baumannii A-74	B	Pus	>1,024	512	128	32	8	512	256	8	256
A. baumannii A-87	C	Sputum	512	128	32	16	4	256	256	4	256
A. baumannii A-88	C	Sputum	256	64	128	32	4	128	128	8	256
Acinetobacter genomic species 3, strain A-178	D	Sputum	128	16	32	8	1	64	64	1	64
A. baumannii A-260	E	Sputum	512	256	128	16	4	256	128	8	128
E. coli XL1-Blue(pA51S3)			256	64	128	16	1	64	64	4	4
E. coli XL1-Blue(pA51SG5)			512	32	1	0.13	32	32	0.13	0.25	2
E. coli XL1-Blue(pBCSK+)			0.5	0.25	0.5	0.13	0.13	0.13	0.25	0.25	1

^aKAN, kanamycin; TOB, tobramycin; AMK, amikacin; ABK, arbekacin; GEN, gentamicin; SISO, sisomicin; ISP, isepamicin; NEO, neomycin; STR, streptomycin.